BEUDAMED
    12 results · 19ms · Sources: EU EUDAMED, US FDA
    Filters FDA Classification × Classification: FDA Class 2 × Clear all

    Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter

    FDA classification
    FDA Class 2 ·Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter

    Sensor, Pressure, Aneurysm, Implantable

    FDA classification
    FDA Class 2 ·Sensor, Pressure, Aneurysm, Implantable

    Tunneled Catheter Remover

    FDA classification
    FDA Class 2 ·Tunneled Catheter Remover

    Gamma Globulin, Fitc, Antigen, Antiserum, Control

    FDA classification
    FDA Class 2 ·Gamma Globulin, Fitc, Antigen, Antiserum, Control

    Nebulizer (Direct Patient Interface)

    FDA classification
    FDA Class 2 ·Nebulizer (Direct Patient Interface)

    Sars-Cov-2 Serology Test

    FDA classification
    FDA Class 2 ·Sars-Cov-2 Serology Test

    Non-Sars Coronavirus Multiplex Nucleic Acid Assay

    FDA classification
    FDA Class 2 ·Non-Sars Coronavirus Multiplex Nucleic Acid Assay

    Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    FDA classification
    FDA Class 2 ·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    FDA classification
    FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    FDA classification
    FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings